Govt moves to limit trade margins on non-scheduled cancer drugs at 30%

Government has decided to cap trade margins at 30% of MRP for all non-scheduled anti-cancer drugs.
The decision aims to limit additional markups and make non-scheduled cancer medicines more affordable for patients.
The move comes ahead of the Supreme Court hearing on medicine pricing scheduled for October 12.
The government had earlier capped trade margins at 30% for 42 selected non-scheduled anti-cancer medicines.

Get 100 stories a day on the app Read, watch & listen · Free on iOS & Android

Newer